# Involvement of Lysosomal Dysfunction and Its Association With Lipotoxic Stress in Palmitate-Treated HepG2 Cells

**Authors:** Susinder Sundaram, Debasree Bishnu, Suman Santra, Swagata Purkait, Debangana Dey, Partha S Mukherjee, Gopal Dhali, Abhijit Chowdhury, Amal Santra

PMC · DOI: 10.7759/cureus.103064 · Cureus · 2026-02-05

## TL;DR

This study shows that lysosomal dysfunction occurs later in liver cells exposed to high fat levels and contributes to cell death in fatty liver disease.

## Contribution

The study reveals lysosomal dysfunction acts as a late-stage integrator of lipotoxic stress in nonalcoholic fatty liver disease.

## Key findings

- Lysosomal destabilization and cathepsin B activation occurred 18 hours after palmitic acid exposure.
- Bafilomycin A1 reduced lysosomal damage and cell death, while chloroquine worsened it.
- Lysosomal dysfunction was linked to mitochondrial failure and increased cell death.

## Abstract

Introduction

Nonalcoholic fatty liver disease (NAFLD), characterized by excessive lipid accumulation in the liver, is a growing global health burden. However, the intracellular events contributing to lipid-related liver injury remain incompletely defined. This study investigated the temporal association of lipotoxic events in HepG2 cells exposed to palmitic acid (PA).

Methods

A time course experiment was conducted to evaluate the effects of lipotoxicity on HepG2 cells. Intracellular reactive oxygen species (ROS), lysosomal destabilization, change in mitochondrial membrane potential (MMP), and cell death were assessed using a fluorescence spectrophotometer and a flow cytometer.

Results

Intracellular lipid accumulation and elevated ROS were detected shortly after PA exposure, followed by later alterations in redox balancecompared with control cells. As treatment progressed, significant lysosomal destabilization became evident from 18 hours onwards, leading to the increased cytosolic level and activity of cysteine protease, cathepsin B, into the cytosol. This lysosomal destabilization was associated with mitochondrial dysfunction, assessed by loss of MMP and release of cytochrome c (Cytc) from mitochondria. These events coincided with increased BAX expression, caspase 3 activation, and ultimately resulted in cell death. Importantly, pretreatment with bafilomycin A1 (BAF) markedly attenuated PA-related lysosomal destabilization, prevented cathepsin B activation, and reduced cell death, whereas a contrasting response was observed with chloroquine (CHQ) pretreatment. Together, these findings support a contributory role of lysosomal dysfunction in PA-associated lipotoxic stress.

Conclusion

This study outlines the temporal sequence of organelle dysfunction during PA-associated lipotoxicity and highlights the association of lysosomal impairment in NAFLD pathogenesis. Rather than serving as an upstream trigger, lysosomal impairment appears to function as a late-stage integrator of lipotoxic stress in this in-vitro HepG2 cells model.

## Linked entities

- **Genes:** BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581], Casp3 (caspase 3) [NCBI Gene 12367]
- **Proteins:** Cyt-c-d (Cytochrome c distal)
- **Chemicals:** palmitic acid (PubChem CID 985), bafilomycin A1 (PubChem CID 72947), chloroquine (PubChem CID 2719)
- **Diseases:** nonalcoholic fatty liver disease (MONDO:0013209)

## Full-text entities

- **Genes:** ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, BCL2 (BCL2 apoptosis regulator) [NCBI Gene 596] {aka Bcl-2, PPP1R50}, CTSB (cathepsin B) [NCBI Gene 1508] {aka APPS, CPSB, KWE, RECEUP}, MAPK8 (mitogen-activated protein kinase 8) [NCBI Gene 5599] {aka JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8}, CTSD (cathepsin D) [NCBI Gene 1509] {aka CLN10, CPSD, HEL-S-130P}, CTSS (cathepsin S) [NCBI Gene 1520], BAX (BCL2 associated X, apoptosis regulator) [NCBI Gene 581] {aka BCL2L4}, CYCS (cytochrome c, somatic) [NCBI Gene 54205] {aka CYC, HCS, THC4}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, POTEF (POTE ankyrin domain family member F) [NCBI Gene 728378] {aka A26C1B, POTE2alpha, POTEACTIN}, ANXA5 (annexin A5) [NCBI Gene 308] {aka ANX5, CPB-I, ENX2, HEL-S-7, PP4, RPRGL3}
- **Diseases:** insulin resistance (MESH:D007333), cytotoxic (MESH:D064420), necrotic (MESH:D009336), liver cell injury (MESH:D006528), Dysfunction (MESH:D006331), liver failure (MESH:D017093), liver damage (MESH:D056486), PA (MESH:D011015), lysosomal dysfunction (MESH:D016464), NAFLD (MESH:D065626), Mitochondrial dysfunction (MESH:D028361), metabolic syndrome (MESH:D024821), cirrhosis (MESH:D005355), hepatocyte injury (MESH:D014947), fat (MESH:D004620), obesity (MESH:D009765), NASH (MESH:D005235), hepatocellular steatosis (MESH:D005234)
- **Chemicals:** MDA (MESH:D008315), fatty acid (MESH:D005227), phosphatidylserine (MESH:D010718), DCF (MESH:D015649), penicillin (MESH:D010406), Palmitate (MESH:D010168), DMEM (-), O2- (MESH:D013481), H2O2 (MESH:D006861), PI (MESH:D011419), ROS (MESH:D017382), CHQ (MESH:D002738), FLUOS (MESH:C097499), 4',6-diamidino-2-phenylindole (MESH:C007293), N-acetyl cysteine (MESH:D000111), PVDF (MESH:C024865), Lipid (MESH:D008055), paraformaldehyde (MESH:C003043), PA (MESH:D019308), GSH (MESH:D005978), CO2 (MESH:D002245), luminol (MESH:D008165), 2',7'-dichlorodihydrofluorescein diacetate (MESH:C110400), streptomycin (MESH:D013307), triglycerides (MESH:D014280), DHE (MESH:C067883), Nile Red (MESH:C044808), AO (MESH:D000165), isopropanol (MESH:D019840), SDS (MESH:D012967), BAF (MESH:C040929), DCFH-DA (MESH:C029569), TMRM (MESH:C401833)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mycoplasma (genus) [taxon 2093]
- **Cell lines:** HepG2 — Homo sapiens (Human), Hepatoblastoma, Cancer cell line (CVCL_0027)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967797/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12967797/full.md

## References

24 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967797/full.md

---
Source: https://tomesphere.com/paper/PMC12967797